Oruka Therapeutics, Inc.
ORKA
Clasificación en acciones
#3289
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Precio por acción
$81.40
Capitalización bursátil
$5.39B
Cambio (1 día)
1.86%
Cambio (1 año)
205.46%
País
US
Comercio Oruka Therapeutics, Inc. (ORKA)
Categoría
Healthcare
Historial del precio de la acción de Oruka Therapeutics, Inc. (ORKA)
Precio más alto de cierre: $79.20 el 2026-10-01
Precio más bajo de cierre: $4.84M el 1997-12-01
Precio más bajo de cierre: $4.84M el 1997-12-01
Historial del precio de la acción de Oruka Therapeutics, Inc. desde 1997 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 94.71% |
| 2025 | 42.90% |
| 2024 | -0.16% |
| 2023 | -22.61% |
| 2022 | -0.72% |
| 2021 | -45.08% |
| 2020 | -24.36% |
| 2019 | -28.32% |
| 2018 | -68.07% |
| 2017 | -46.86% |
| 2016 | -51.59% |
| 2015 | -15.86% |
| 2014 | -43.56% |
| 2013 | -26.26% |
| 2012 | -71.67% |
| 2011 | -61.96% |
| 2010 | 8.83% |
| 2009 | -51.11% |
| 2008 | -84.91% |
| 2007 | -76.28% |
| 2006 | 3.31% |
| 2005 | -17.12% |
| 2004 | -4.50% |
| 2003 | 257.05% |
| 2002 | -86.09% |
| 2001 | -11.58% |
| 1999 | 76.44% |
| 1998 | -48.78% |
| 1997 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $531.67 | 24.68% |
US
|
|
| $237.10 | 783.04% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $895.07 | 9.94% |
NL
|
|
| $288.17 | 1.24% |
BE
|
